|
|
Article: FDA acts to improve drug safety and quality; FDA strengthens its efforts on unapproved prescription drug products containing carbinoxamine.
- Article from:
- M2 Presswire
- Article date:
- June 8, 2006
CopyrightCOPYRIGHT 2006 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-8 June 2006-US FDA: FDA acts to improve drug safety and quality; FDA strengthens its efforts on unapproved prescription drug products containing carbinoxamine(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:08062006
The Food and Drug Administration (FDA) announced the strengthening of its efforts against unapproved drug products.
The activity will begin with prescription products containing the antihistamine carbinoxamine because of safety concerns regarding their use in children under 2 years of age.
The agency is issuing a final guidance document outlining its approach to addressing other medicines that are marketed without FDA ...